Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 1
1998 1
1999 1
2000 1
2001 6
2002 2
2003 2
2004 3
2005 4
2006 3
2007 3
2008 4
2009 4
2010 4
2011 8
2012 4
2013 4
2014 6
2015 8
2016 16
2017 9
2018 5
2019 8
2020 19
2021 17
2022 17
2023 21
2024 20
2025 0

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

188 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab for COPD with Type 2 Inflammation Indicated by Eosinophil Counts.
Bhatt SP, Rabe KF, Hanania NA, Vogelmeier CF, Cole J, Bafadhel M, Christenson SA, Papi A, Singh D, Laws E, Mannent LP, Patel N, Staudinger HW, Yancopoulos GD, Mortensen ER, Akinlade B, Maloney J, Lu X, Bauer D, Bansal A, Robinson LB, Abdulai RM; BOREAS Investigators. Bhatt SP, et al. N Engl J Med. 2023 Jul 20;389(3):205-214. doi: 10.1056/NEJMoa2303951. Epub 2023 May 21. N Engl J Med. 2023. PMID: 37272521 Clinical Trial.
Long-term safety and efficacy of tezepelumab in people with severe, uncontrolled asthma (DESTINATION): a randomised, placebo-controlled extension study.
Menzies-Gow A, Wechsler ME, Brightling CE, Korn S, Corren J, Israel E, Chupp G, Bednarczyk A, Ponnarambil S, Caveney S, Almqvist G, Gołąbek M, Simonsson L, Lawson K, Bowen K, Colice G; DESTINATION study investigators. Menzies-Gow A, et al. Lancet Respir Med. 2023 May;11(5):425-438. doi: 10.1016/S2213-2600(22)00492-1. Epub 2023 Jan 23. Lancet Respir Med. 2023. PMID: 36702146 Clinical Trial.
Beta-blockers in asthma: myth and reality.
Tiotiu A, Novakova P, Kowal K, Emelyanov A, Chong-Neto H, Novakova S, Labor M. Tiotiu A, et al. Among authors: emelyanov a. Expert Rev Respir Med. 2019 Sep;13(9):815-822. doi: 10.1080/17476348.2019.1649147. Epub 2019 Aug 2. Expert Rev Respir Med. 2019. PMID: 31352857 Review.
Phase separation drives heterochromatin domain formation.
Strom AR, Emelyanov AV, Mir M, Fyodorov DV, Darzacq X, Karpen GH. Strom AR, et al. Among authors: emelyanov av. Nature. 2017 Jul 13;547(7662):241-245. doi: 10.1038/nature22989. Epub 2017 Jun 21. Nature. 2017. PMID: 28636597 Free PMC article.
Liraglutide in Children and Adolescents with Type 2 Diabetes.
Tamborlane WV, Barrientos-Pérez M, Fainberg U, Frimer-Larsen H, Hafez M, Hale PM, Jalaludin MY, Kovarenko M, Libman I, Lynch JL, Rao P, Shehadeh N, Turan S, Weghuber D, Barrett T; Ellipse Trial Investigators. Tamborlane WV, et al. N Engl J Med. 2019 Aug 15;381(7):637-646. doi: 10.1056/NEJMoa1903822. Epub 2019 Apr 28. N Engl J Med. 2019. PMID: 31034184 Clinical Trial.
p16High senescence restricts cellular plasticity during somatic cell reprogramming.
Grigorash BB, van Essen D, Liang G, Grosse L, Emelyanov A, Kang Z, Korablev A, Kanzler B, Molina C, Lopez E, Demidov ON, Garrido C, Liu F, Saccani S, Bulavin DV. Grigorash BB, et al. Among authors: emelyanov a. Nat Cell Biol. 2023 Sep;25(9):1265-1278. doi: 10.1038/s41556-023-01214-9. Epub 2023 Aug 31. Nat Cell Biol. 2023. PMID: 37652981
Progress in Occupational Asthma.
Tiotiu AI, Novakova S, Labor M, Emelyanov A, Mihaicuta S, Novakova P, Nedeva D. Tiotiu AI, et al. Among authors: emelyanov a. Int J Environ Res Public Health. 2020 Jun 24;17(12):4553. doi: 10.3390/ijerph17124553. Int J Environ Res Public Health. 2020. PMID: 32599814 Free PMC article. Review.
[New clinical guidelines for COPD - a paradigm shift: A review].
Avdeev SN, Leshchenko IV, Aisanov ZR, Arkhipov VV, Belevskiy AS, Ovcharenko SI, Emelyanov AV, Sinopalnikov AI, Shmelev EI, Chuchalin AG. Avdeev SN, et al. Among authors: emelyanov av. Ter Arkh. 2024 Apr 16;96(3):292-297. doi: 10.26442/00403660.2024.03.202646. Ter Arkh. 2024. PMID: 38713046 Review. Russian.
p16High immune cell - controlled disease tolerance as a broad defense and healthspan extending strategy.
Triana-Martinez F, Pierantoni A, Graca D, Bergo V, Emelyanov A, Grigorash BB, Tsuji S, Nakano S, Grosse L, Brglez V, Marty P, Dellamonica J, Fornace AJ Jr, Trompouki E, Hara E, Seitz-Polski B, Bulavin DV. Triana-Martinez F, et al. Among authors: emelyanov a. bioRxiv [Preprint]. 2024 Jul 15:2024.07.15.603540. doi: 10.1101/2024.07.15.603540. bioRxiv. 2024. PMID: 39026790 Free PMC article. Preprint.
188 results